AZURITY SOLUTIONS E-Z RX Trademark

Trademark Overview

On Friday, March 25, 2022, a trademark application was filed for AZURITY SOLUTIONS E-Z RX with the United States Patent and Trademark Office. The USPTO has given the AZURITY SOLUTIONS E-Z RX trademark a serial number of 97330750. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, August 28, 2024. This trademark is owned by Azurity Pharmaceuticals, Inc.. The AZURITY SOLUTIONS E-Z RX trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business management services to pharmacies to monitor drug inventories and ensure availability to patients
azurity solutions e-z rx

General Information

Serial Number97330750
Word MarkAZURITY SOLUTIONS E-Z RX
Filing DateFriday, March 25, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, August 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 7, 2023

Trademark Statements

Goods and ServicesBusiness management services to pharmacies to monitor drug inventories and ensure availability to patients
NOT AVAILABLE"SOLUTIONS" AND "RX"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, January 27, 2023
Primary Code035
First Use Anywhere DateFriday, March 25, 2022
First Use In Commerce DateFriday, March 25, 2022

Trademark Owner History

Party NameAzurity Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801
Party NameAzurity Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801

Trademark Events

Event DateEvent Description
Wednesday, March 30, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 10, 2023ASSIGNED TO EXAMINER
Wednesday, January 18, 2023NON-FINAL ACTION WRITTEN
Wednesday, January 18, 2023NON-FINAL ACTION E-MAILED
Wednesday, January 18, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 5, 2023TEAS STATEMENT OF USE RECEIVED
Monday, June 5, 2023USE AMENDMENT FILED
Friday, June 30, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 5, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 2, 2023SU - NON-FINAL ACTION - WRITTEN
Wednesday, August 2, 2023NON-FINAL ACTION E-MAILED
Wednesday, August 2, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 2, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 2, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, December 2, 2023SU - FINAL REFUSAL - WRITTEN
Saturday, December 2, 2023FINAL REFUSAL E-MAILED
Saturday, December 2, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, March 1, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, March 1, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, August 28, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, August 28, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Related Keywords

solutions azurity inventories ensure availability patients drug monitor management services pharmacies business